by Rakovina Therapeutics | Jun 20, 2025 | Uncategorized
Download Vancouver, British Columbia – June 6, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery,...
by Rakovina Therapeutics | Jun 2, 2025 | Uncategorized
All dollar amounts reflected in Canadian dollars unless otherwise stated. Vancouver, British Columbia, June 2, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing novel DNA-damage response...
by Rakovina Therapeutics | May 30, 2025 | Uncategorized
DOWNLOAd Vancouver, British Columbia, May 5, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is...
by Rakovina Therapeutics | May 28, 2025 | Uncategorized
VANCOUVER, British Columbia, May 28, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), announces that in accordance with the terms of an indenture entered into between the Company and Odyssey Trust Company dated May 29, 2023 (the...
by Rakovina Therapeutics | May 15, 2025 | Uncategorized
$3 Million Lead Order from Strategic Investors Supports Bold Transformation Vancouver, British Columbia, May 15, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies...
by Rakovina Therapeutics | May 5, 2025 | Uncategorized
Vancouver, British Columbia, May 5, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to...